Saturday 17 October 2026
Export SNOA’s income statement to Excel — free account
Sonoma Pharmaceuticals, Inc.
SNOA Healthcare Drug Manufacturers Specialty & Generic
Sonoma Pharmaceuticals, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $19.5 million, up 36.7% from fiscal 2025. In the quarter to June 2026, revenue grew 59.6%, EPS grew 88.2% and free cash flow grew 69.3%, each against the same quarter a year earlier.
1.13
0.02
−1.74%
Follow SNOA
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(76.14%) | (81.19%) | (84.60%) | (42.52%) | |
Piotroski F-Score |
4 | 4 | 3 | 5 | |
| (25.26%) | (24.70%) | (22.96%) | (13.85%) | ||
ROIC |
(259.23%) | (198.48%) | (220.99%) | (69.96%) | |
Return on Tangible Assets |
(41.11%) | (40.89%) | (41.90%) | (20.38%) | |
Average Days of Receivables |
58.25 | 49.06 | 47.23 | 52.98 | |
Free Cash Flow per Share |
(1.42) | (2.17) | (2.45) | (0.69) | |
Free Cash Flow |
(2.34) | (3.72) | (4.12) | (2.65) | |
Capital Expenditures |
(0.16) | (0.21) | (0.19) | (0.09) | |
| Other line items | |||||
Cash ROIC |
(34.37%) | (62.06%) | (75.08%) | (22.25%) | |
Accounts Receivable Turnover |
5.78 | 7.40 | 8.21 | 7.58 | |
Accounts Payable Turnover |
9.71 | 7.21 | 8.42 | 6.32 | |
Inventory Turnover |
3.26 | 3.20 | 3.69 | 3.53 | |
Average Days of Payables |
48.55 | 54.82 | 57.94 | 59.72 | |
Days of Inventory on Hand |
125.67 | 123.32 | 110.01 | 103.19 | |
Tax Rate |
0.02 | (0.02) | (0.07) | 0.00 | |
Research and Development Expense of Revenue |
11.85% | 12.06% | 11.63% | 10.37% | |
Selling, General and Administrative Expense of Revenue |
44.25% | 41.71% | 38.94% | 34.95% | |
Share Based Compensation of Revenue |
1.17% | 1.18% | 1.31% | 1.17% | |
Operating CF/Net income |
0.63 | 1.04 | 1.24 | 1.13 | |
Depreciation/Fixed assets |
0.48 | 0.44 | 0.45 | 0.47 | |
Capex/Depreciation |
(1.21) | (1.53) | (1.38) | (0.65) | |
Revenue per Share |
10.29 | 10.35 | 11.60 | 5.70 | |
Operating CF per Share |
(1.32) | (2.05) | (2.34) | (0.67) | |
Capex per Share |
(0.10) | (0.12) | (0.11) | (0.02) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.00 |
Columns are period end dates